Get started

Biotechnology

Short biotechnology again near trend line resistance Biotech bubble has burst. Every rallies are to be sold, and despite the euphoria/new highs in S&P and Nasdaq have barely registered a decent retracement in the biotech sector.. Here's a larger picture of how far biotechs have went since 2008: The uptrend in S&P is limited, and it will only be a matter of time before it collapses off this rising wedge. However it is also risky to go against Janet Yellen (FED) with unlimited cash in its balance sheet. A short on a specific sector would be a much safer bet. ------------------- I'm long on ZBIO (3x short biotech ETF) at 22.51, with a target around $30~40.
NASDAQ:NBIShort
by LastBattle
7
#Nasdaq #Biotech It ought to correct overboughtIt ought to correct overbought Nasdaq Biotechnology Index: The Nasdaq Biotech index has grown about 50 percent since Yellen's valuation comments. Superarando por mucho el desempeño de los indices composite y S&P500, this boom is due primarily to the pharmaceutical companies who have monopolized the attention of investors the past few months, beyond the debate of whether exist a bubble formation the Nasdaq Biotechnology Index It ought to correct their overbought at least 6% as it has done in later months www.bloomberg.com
NASDAQ:NBIShort
by claudiowall
1